Feng, Yahui
Qi, Saibing
Hu, Yu
Yan, Wen
Ji, Yanping
Wang, Mingyang http://orcid.org/0000-0001-7201-5090
Gong, Xiaowen
Shen, Qiujin
Zhang, Wei
Liu, Huilan
Zhang, Xianjing
Chen, Mengyun
Chen, Erling
Zhai, Xiaolin
He, Yi http://orcid.org/0000-0001-5726-3686
Yang, Donglin http://orcid.org/0000-0002-8567-894X
Pang, Aiming
Han, Mingzhe http://orcid.org/0000-0002-1720-6799
Gale, Robert Peter http://orcid.org/0000-0002-9156-1676
Sun, Zimin
Jiang, Erlie
Chen, Junren http://orcid.org/0000-0003-3691-4931
Article History
Received: 12 September 2024
Revised: 18 September 2024
Accepted: 20 September 2024
First Online: 25 September 2024
Competing interests
: RPG is a consultant to Antengene Biotech LLC, Ascentage Pharma Group and NexImmune Inc.; Medical Director, FFF Enterprises Inc.; Board of Directors: Russian Foundation for Cancer Research Support; and Scientific Advisory Boards, Nanexa AB and StemRad Ltd.
: Approved by the Academic Committee (IIT2021006) of the Institute of Hematology, Chinese Academy of Medical Sciences (IHCAMS) and the Ethics Review Committees of IHCAMS (IIT2021006-EC-1) and the First Affiliated Hospital of University of Science and Technology of China (FAHUSTC; 2022-RE-070). Subjects gave written informed consent consistent with precepts of the Helsinki Declaration.